Low-dose oral minoxidil, the hair growth drug which is the active ingredient in Rogaine, may be safe and effective for ...

Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.

Every treatment bag should include an unlimited supply of humor. Stuff will happen. It’ll be hard, but you may learn to laugh ...

Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for ...

First-line Rybrevant plus Lazcluze improved survival versus the current standard of care in patients with mutated advanced or ...

Psilocybin-assisted psychotherapy (PAP) has been shown to potentially have mental health benefits for patients with cancer, ...

Losing my hair after chemo was devastating, and I struggled to accept how it changed my appearance and self-image.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

2024 was a year of resilience after a myeloma diagnosis, marked by a return to public speaking, a documentary filming ...

Stereotactic body radiation therapy combined with Nexavar showed a clinically important improvement in overall survival in ...

A Biologics License Application has been submitted to the FDA for treatment with the kidney cancer imaging PET drug product, Zircaix®.

F-DOPA PET−guided, dose-escalated, hypofractionated proton beam therapy led to improved OS in older patients with newly ...